Health Care Equipment & Services

Explore MCKESSON CORP’s insider sales: LeAnn B. Smith’s 1,810‑share June 1 drop, trading patterns, and what it signals for investors.

Intuitive Surgical insider trading shows a strategic buy‑sell balance, with executives buying at $77 and selling at $420—indicating confidence and liquidity planning.

HealthStream insider sale: board member Linda Rebrovick sells 2,000 shares at $25.59 under a 10b5‑1 plan—routine liquidity move, not a confidence shift.

Glaukos insider buys reveal board confidence: 10,000+ shares bought at $103.12, boosting equity and backing the company’s micro‑injection glaucoma platform amid regulatory milestones.

McKesson insider buying signals confidence: executives purchase RSUs amid strategic analytics push, boosting investor optimism and potential share price rebound.

HRT Financial’s sudden $0.09 buy‑the‑dip of 1.5m WORK Medical shares shows a cautious, short‑term spec strategy amid a highly volatile, low‑liquidity medical‑tech niche—highlighting both rebound potential and high risk.

Insider confidence in WORK Medical Technology: HRT Financial LP holds $24.8k of stock at $0.11/share. Learn how insider stakes can signal upside amid a sharp 91% price drop.

CEO Michael Mahoney’s massive $0 sale of 386K Boston Scientific shares raises questions about exec confidence and hints at short‑term volatility, yet the firm’s robust pipeline still offers upside.

Progyny insider trades show disciplined, rule‑based selling—minimal impact, no distress signals, and a positive outlook for growth‑stage fertility‑benefits firm.

Tenet Healthcare insider sells 5,723 shares at $175‑$177, boosting liquidity but little impact on price. Investors should monitor future trades, valuation, and sector trends for strategy insights.